“I had lymphoma in 2005 and to hear of the breakthroughs in the past 12 + years is hopeful and amazing. Thank you for taking the time to put this together and thank you to the Dr and everyone for the research they continue to do." - Webcast Participant
Learn more by participating over the telephone and online in upcoming webcasts. Visit this page to access virtual lectures, audio replays and program slides from past programs.
New treatment horizon: CAR T-Cell Therapy
Thursday, September 26, 4:00 pm EDT
Surgery, chemotherapy, and radiation have been the foundation of cancer treatment for decades. Cancer researchers are now studying how harnessing the immune system can help destroy cancer cells. One type of immunotherapy involves engineering patients’ own T-cells to have a unique receptor, called a chimeric antigen receptor (CAR), enabling these immune cells to recognize and attack cancer cells. CAR T-cell therapy is currently used for some types of blood cancers and in development for hundreds of other cancers types. In this presentation, Dr. Hay will present how a CAR T-cell is made and how it works, as well as the current and future indications for this novel therapy